Institutional investors hold a majority ownership of AMGN through the 83.14% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended March 2013, these large investors purchased a net $6.4 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
WINSLOW CAPITAL MANAGEMENT LLC Bought 4.9 Million shares of Amgen Inc
ING INVESTMENT MANAGEMENT CO. Bought 2.8 Million shares of Amgen Inc
ROBECO INSTITUTIONAL ASSET MANAG... Bought 2.2 Million shares of Amgen Inc